SAM
IDXX icon

Sentinel Asset Management’s Idexx Laboratories IDXX Stock Holding History

Sentinel Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-68,380
Closed -$4.15M – 250
2014
Q1 		$4.15M Buy
68,380
+2,260
+3% +$135K 0.08% 207
2013
Q4 		$3.52M Buy
66,120
+1,040
+2% +$54.7K 0.07% 237
2013
Q3 		$3.24M Sell
65,080
-8,820
-12% -$424K 0.07% 234
2013
Q2 		$3.32M Buy
+73,900
New +$3.23M 0.07% 231

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Sentinel Asset Management's IDXX Position: Q2 2014 in Review

Sentinel Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2014, closing a stake of 68,380 shares — an estimated $4.15M sold.

Sentinel Asset Management first reported a position in IDXX in Q2 2013 and held it in 4 quarters. The position peaked at $4.15M in Q1 2014. 306 funds tracked by Wall St. Rank hold IDXX as of Q2 2014.

  • Sentinel Asset Management reported no remaining Idexx Laboratories position as of Q2 2014 after selling out during the quarter.
  • Sentinel Asset Management sold 68,380 Idexx Laboratories shares in Q2 2014, an estimated $4.15M.
  • Sentinel Asset Management first reported a position in Idexx Laboratories in Q2 2013 and held it in 4 quarters.
  • Sentinel Asset Management's Idexx Laboratories position peaked at $4.15M in Q1 2014.
  • 306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2014.

Based on Sentinel Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.